Pfizer Inc and BioNTech SE said on Wednesday that real-world data from Israel suggests their coronavirus vaccine is 94 per cent effective in preventing asymptomatic infections, meaning it could significantly reduce transmission.
Pfizer, BioNTech say Israeli data suggests vaccine greatly reduces asymptomatic infections
